Quarterly Result5 Feb 2026, 01:49 pm
ANG Lifesciences India Ltd. to Approve Unaudited Standalone and Consolidated Financial Results on Feb 14, 2026
AI Summary
ANG Lifesciences India Ltd. has announced that its Board of Directors will meet on February 14, 2026, to consider and approve the Standalone and Consolidated Un-Audited Financial Results for the quarter and nine months ended 31 December, 2025. The meeting will be held at the company's registered office in Amritsar. The trading window for insider trading will be closed from January 1, 2026, and will reopen 48 hours after the results are made public on February 14, 2026.
Key Highlights
- ANG Lifesciences India Ltd. to consider and approve Standalone and Consolidated Un-Audited Financial Results for the quarter and nine months ended 31 December, 2025.
- Board Meeting scheduled on Saturday, 14th February, 2026.
- Trading Window for insider trading to be closed from 1st January, 2026.
- Trading Window to reopen 48 hours after the results are made public on 14th February, 2026.
Price Impact
More from ANG